Clinical Trial Update: A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating Fasudil Hydrochloride for gene-specific ovarian cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Fasudil Hydrochloride (fasudil hydrochloride)

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: Ovarian Cancer | Phase 2 | Status: RECRUITING